231 – 240 of 376
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Clonal Expansion of T/NK-Cells during Tyrosine Kinase Inhibitor Dasatinib Therapy
(
- Contribution to journal › Published meeting abstract
-
Mark
Permissive roles of hematopoietin and cytokine tyrosine kinase receptors in early T cell development
(
- Contribution to journal › Article
-
Mark
Protein kinase B (c-akt) regulates hematopoietic lineage choice decisions during myelopoiesis
(
- Contribution to journal › Article
-
Mark
Maintenance Treatment with 5-Azacitidine for Patients with High Risk Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia Following MDS (MDS-AML) in Complete Remission (CR) after Induction Chemotherapy
(
- Contribution to journal › Published meeting abstract
-
Mark
Novel markers of normal and neoplastic human plasmacytoid dendritic cells
(
- Contribution to journal › Scientific review
-
Mark
Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma
(
- Contribution to journal › Article
-
Mark
Familial Aggregation of Multiple Myeloma and Its Precursor Monoclonal Gammopathy of Undetermined Significance (MGUS): A Population-Based Study in Sweden
(
- Contribution to journal › Published meeting abstract
-
Mark
Smad4 as a Therapeutic Target in Nup98-HoxA9-Induced Leukemia.
(
- Contribution to journal › Published meeting abstract
-
Mark
Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group
(
- Contribution to journal › Article
-
Mark
Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group
(
- Contribution to journal › Article